Dimethylformamide → HCID 13338435, Verbindung
Reaktionsgleichung
Cl[C:2]1[C:3]2[N:11]([CH3:12])[N:10]=[C:9]([CH3:13])[C:4]=2[N:5]=[C:6]([CH3:8])[N:7]=1.[NH2:14][CH:15]([CH3:19])[C:16](=[O:18])[CH3:17].C(N([CH2:25][CH3:26])CC)C.CN(C)C=[O:30]>>[CH3:12][N:11]1[C:3]2[C:2]([NH:14][CH:15]([C:16]3([CH3:17])[O:30][CH2:25][CH2:26][O:18]3)[CH3:19])=[N:7][C:6]([CH3:8])=[N:5][C:4]=2[C:9]([CH3:13])=[N:10]1Komponenten
5
Versuchsvorschrift
A mixture of 9.5 g (0.05 mol) of 7-chloro-1,3,5-trimethyl-1H-pyrazolo[4,3-d]pyrimidine (Example 3), 10 g (0.075 mol) of 3-amino-2-butanone, ethylene ketal, and 14 ml of triethylamine in 30 ml of dimethylformamide is stirred at 50°-55° C. for 24 hours. The mixture is evaporated in vacuo, the residue is dissolved in methylene dichloride and washed with ammonium hydroxide solution. The organic layer is dried over MgSO4 and evaporated in vacuo. The residue is crystallized from pet ether to give 12.6 g (87%) of 1,3,5-trimethyl-N-[1-(2-methyl-1,3-dioxolan-2-yl)ethyl]-1H-pyrazol[4,3-d]pyrimidin-7-amine, mp 101°-103° C.
Aufarbeitung
- customThe mixture is evaporated in vacuo
- dissolutionthe residue is dissolved in methylene dichloride
- washwashed with ammonium hydroxide solution
- dry with materialThe organic layer is dried over MgSO4
- customevaporated in vacuo
- customThe residue is crystallized from pet ether
Quellen und Nachweise
- ORD-Eintrag
- ord-9fa8df680800474a888a1a2228cdd425
- Quelldatensatz
- uspto-grants-1984_09
- Patentnummer
- US04469868
Notizen zur Reaktion
Wird geladen…